Renal disease is a common complication of diabetes. The initiating events in diabetic nephropathy are triggered by hyperglycemia and, possibly, advanced glycation end products. Subsequently, excess levels of vasoactive peptides (especially endothelin-1 (ET-1)) accumulate in the diabetic kidney, and there is evidence that these peptides mediate many of the pathophysiological changes associated with diabetic renal disease. These changes include an excess deposition of extracellular matrix proteins into the glomerular basement membrane and renal mesangial cell hypertrophy. Our transcriptional profiling studies have revealed that the p8 gene, which encodes a putative basic helix-loop-helix protein, is strongly induced in ET-1-treated renal mesangial cells and in an animal model of diabetic nephropathy. RNA interference experiments indicated that the p8 gene is required for ET-1-induced mesangial cell hypertrophy. Here, we show that the p8 polypeptide is a phosphoprotein subject to constitutive degradation by the ubiquitin/proteasome system. This degradation is mediated by phosphatidylinositol 3-kinase and protein kinase B/Akt. By contrast, stabilization of the p8 protein requires glycogen synthase kinase-3. Finally, short interfering RNAmediated RNA interference experiments indicated that ET-1-stimulated mesangial cell hypertrophy and p8 mRNA induction require the NFAT4 transcription factor. Thus, p8 levels in the cell are likely maintained by a balance between signal-dependent transcriptional induction and proteolysis.
Diabetic nephropathy is a common complication of both type I and II diabetes and represents the major cause of end stage renal failure in the Western World (1) . The renal disease characteristic of diabetes mellitus arises relatively quickly with the onset of frank hyperglycemia and is marked by elevations in circulating vasoactive peptides, glomerular mesangial cell hypertrophy, and proliferation as well as the excess deposition of extracellular matrix proteins into the glomerular basement membrane (2, 3) . Mesangial cell hypertrophy is characterized at the cellular level as an increase in overall protein synthesis in the absence of a concomitant increase in overall DNA synthesis. Multiple extracellular stimuli are thought to be involved in the pathophysiology of diabetic mesangial cell hypertrophy. Prominent among these are vasoactive peptides such as endothelin-1 (ET-1), 1 vasopressin, angiotensin II, and transforming growth factor-␤ (2, 4). Our recent findings indicate that renal mesangial cell hypertrophy is controlled by mechanisms similar to those governing cardiomyocyte hypertrophy (9) . In particular, in addition to the recruitment of MAPKs, mesangial cell hypertrophy requires activation of the phosphatidylinositol 3-kinase (PI3K) pathway (9) .
Our studies have been aimed at the identification of mechanisms coupling signaling pathways with more distal elements that trigger renal mesangial cell hypertrophy. Using a combined pharmacological and transcriptional profiling approach, we have identified genes induced by ET-1 after the period of treatment needed to trigger hypertrophy. Seven genes were identified; of these, one transcript, encoding the small basic helix-loop-helix protein p8, was strikingly and stably induced by ET-1 (9) .
The p8 gene has been conserved evolutionarily, with homologs found in man, rat, mouse, and Xenopus. p8 was initially isolated as a gene strongly induced during acute pancreatitis (10 -12) . In several cell lines, the p8 gene is transiently induced in response to stress and thus may be part of a general defense mechanism protecting against cellular injury (10, 11) . Consistent with this, targeted disruption of the murine p8 gene, although not lethal, does result in higher mortality in the lipopolysaccharide injection model of sepsis (13) . Other studies have implicated p8 gene expression with metastatic potential (14) , and the p8 gene may also be involved in the control of cell proliferation, although the precise function of p8 in cell proliferation is unclear. Thus, disruption of the p8 gene suppresses transformation associated with ectopic expression of ras and adenoviral E1A, blunting the growth of these transformed cells in soft agar and preventing the formation of tumors in mice injected with ras/E1A-transformed p8 Ϫ/Ϫ cells (15) . By contrast, p8
Ϫ/Ϫ cells proliferate more rapidly in culture and are resistant to chemical stress-induced apoptosis (16) .
The product of the human p8 gene is an 82-amino acid protein with no significant homology to any other known eukaryotic protein. Analysis of the primary structure of p8 revealed a canonical bipartite nuclear localization signal and a potential DNA interaction motif (see Fig. 1A ) (13) . Accordingly, recombinant p8 has been shown to bind in vitro to DNA, an interaction enhanced in vitro by phosphorylation of the recombinant protein with protein kinase A (17) .
Consistent with the possibility that p8 is regulated by phosphorylation, 17% of the amino acid composition of p8 is composed of phosphorylatable residues (17) . In addition, the p8 protein contains an N-terminal PEST (Pro/Glu/Ser/Thr-rich) region, suggesting regulation of p8 levels by the ubiquitin (Ub)/ proteasome system (see Fig. 1A ) (18) .
We have previously dissected the rat renal mesangial cell molecular signaling events activated by ET-1 that are required for hypertrophy and found that hypertrophy requires activation of the ERK and JNK MAPKs as well as PI3K-dependent signaling, possibly through NFAT proteins (9) . ET-1 induction of the p8 gene requires activation of these same signaling pathways. The p8 gene is also strongly induced in the kidneys of rats made diabetic with streptozotocin. Experiments using RNA interference (RNAi) to specifically silence mesangial cell p8 mRNA identified the p8 gene as a necessary component in the ET-1-stimulated transcriptional program that triggers mesangial cell hypertrophy (9) .
Although there is a substantial understanding of the regulation of p8 gene expression and even of the putative biological function(s) of the p8 gene product, little or nothing is known about the regulation of the p8 polypeptide itself or of the regulation p8 protein levels in the cell. In our initial studies of the endogenous mesangial cell p8 polypeptide, we were intrigued to find that p8 was almost undetectable unless cells were preincubated with inhibitors of the Ub/proteasome system. Under these circumstances, we could detect a modest ET-1-stimulated increase in the p8 protein; however, the significance of this increase was unclear given the conditions necessary to visualize it, and we were compelled to ascertain whether or not p8 protein stability, as with p8 mRNA, is regulated by extracellular signaling pathways.
Here, we show that the p8 protein is heavily phosphorylated in vivo. We found that the regulation of p8 polypeptide levels runs counter to the regulation of p8 mRNA. p8 is a predominantly nuclear protein that is constitutively degraded through a proteasome-dependent mechanism, and this degradation is regulated by the Akt pathway. Accordingly, p8 stability requires in vivo GSK3, the activity of which is inhibited by Akt. GSK3 also directly phosphorylates p8 in vitro. Overexpression of a dominant-negative Akt mutant or the addition of LY294002, a PI3K inhibitor, stabilized the p8 protein and confirmed that destabilization of p8 is mediated by the PI3K/ Akt pathway. The proteasome inhibitor lactacystin substantially enhanced the levels of endogenous and recombinant p8. LiCl, a GSK3 inhibitor, destabilized p8 by a process that could be reversed with proteasome inhibitors (lactacystin). Finally, our RNAi experiments indicated that ET-1-induced mesangial cell hypertrophy and p8 mRNA induction require NFAT4, a transcription factor that is itself inhibited by GSK3 and activated by Akt-mediated GSK3 inhibition.
EXPERIMENTAL PROCEDURES
Cell Culture-Primary rat renal mesangial cells were isolated as described (9) . Mesangial cells were cultured in RPMI 1640 medium and 10% fetal bovine serum (FBS). Human embryonic 293 cells were cultured in Dulbecco's modified Eagle's medium and 10% FBS. ET-1, lactacystin, LY294002, and SB203580 were from Calbiochem. Calyculin A was from Cell Signaling Technology. Immunofluorescence studies of NIH3T3 and HeLa cells were performed as described (19) .
DNA and Vectors-pcDNA-p8-His 5 was obtained by mutating by PCR the stop codon of the full-length human p8 cDNA and introducing in-frame a short sequence coding for five histidines, followed by a stop codon. The construct was subcloned into the vector pcDNA3.1/hygro. pEGFP-p8 was obtained by cloning full-length human p8 in-frame at the C terminus of the enhanced green fluorescent protein (EGFP). Vectors encoding wild-type and kinase-dead GSK3␤ have been described (20) . pUSEamp vectors expressing dominant-negative and membrane-targeted, constitutively active Akt1 were from Upstate Biotechnology, Inc.
Transfections, Kinase Assays, and Western Blot Analysis-293 cells were transfected using LipofectAMINE (Invitrogen). Cells at 70 -80% confluency were transfected as suggested by the manufacturer. Cells were used after 24 h. Drugs (LY294002 (20 M), SB203580 (20 M), lactacystin (10 M), and calyculin A (0.1 M)) were added to the medium 3 h prior to lysing the cells. In cotransfection experiments, cells were lysed in 400 l of Laemmli denaturing loading buffer. Equal amounts of total protein were separated on 15% SDS-polyacrylamide gels. Immunoblotting was performed with either our rabbit anti-p8 polyclonal antibody or commercial antibody against histidine (G-18), NFAT4 (F-1), NFAT1 (7A6), Ub (FL-76), or c-Myc (9E10) (Santa Cruz Biotechnology). Polypeptides were detected with the enhanced chemiluminescence system.
Mesangial cells at 70% confluency were serum-starved for 48 h in Dulbecco's modified Eagle's medium and 0.5% FBS and then stimulated for 24 h with vehicle or 100 nM ET-1 in the presence or absence of vehicle or 10 M lactacystin. Cells were lysed in SDS-PAGE loading buffer, and 60 g of total proteins were subjected to SDS-PAGE and immunoblotting with rabbit anti-p8 polyclonal antibody. To detect endogenous p8, the membrane was developed using the SuperSignal system (Pierce).
For treatment of the recombinant p8 protein with -phosphatase, 293 cells were transfected with pcDNA-p8-His 5 as described above. After 24 h, the cells were lysed in 900 l of 8 M urea and 100 mM Tris (pH 8) containing 10 mM phenylmethylsulfonyl fluoride. The recombinant p8 protein was immobilized for 3 h at 4°C on 60 l of nitrilotriacetic acid-agarose resin (QIAGEN Inc.). The beads were washed twice with lysis buffer, twice with 150 mM NaCl and 50 mM Tris (pH 8), and twice with -phosphatase buffer. The immobilized p8 protein was distributed into three aliquots. One was left untreated. The others were treated at 30°C for 40 min with 10 units/l -phosphatase in the presence or absence of 2 mM MnCl 2 , which is required for -phosphatase activity. Phosphatase reactions were stopped with 25 mM NaF. The samples were then subjected to SDS-PAGE and immunoblotting with anti-His antibody. In experiments of p8 ubiquitination, p8-His 5 was transfected alone or together with Myc-tagged Ub and purified from the total cellular lysates as described above. The immunoblots were decorated using anti-Ub or anti-Myc antibody and ECL solutions. For the kinase assays, 293 cells were transfected with plasmids encoding Myc-tagged wild-type or kinase-dead GSK3␤. The next day, cells were washed with cold phosphate-buffered saline and then lysed in 900 l of ice-cold radioimmune precipitation assay buffer containing protease and phosphatase inhibitors. Equal amounts of total protein extracts were incubated with 2 g of antibody 9E10 for 2 h at 4°C with 60 l of protein G-agarose (50%). The immunocomplexes were washed three times with lysis buffer and twice with kinase buffer (20 mM Mops (pH 7.2), 2 mM EGTA, 10 mM MgCl 2 , 1 mM dithiothreitol, and 0.1% Triton X-100) and then incubated for 20 min at 30°C with 1 g of bacterially expressed p8 protein, 100 M ATP, and 2 Ci of [ 32 P]ATP. Reactions were stopped by the addition of 2ϫ SDS-PAGE loading buffer, separated by 15% SDS-PAGE, and subjected to autoradiography.
In Vivo Labeling with 32 
PO 4 and [ 35 S]
Methionine-293 cells transfected as described above were incubated for 3 h in 3 ml of phosphatefree medium (Dulbecco's modified Eagle's medium) containing 1 mCi/ml carrier-free 32 PO 4 . Cells were washed with cold phosphate-buffered saline and lysed as described above in 900 l of ice-cold radioimmune precipitation assay buffer containing protease and phosphatase inhibitors. Equal cpm of labeled extract were incubated with 4 g of either anti-His or anti-GFP antibody (Santa Cruz Biotechnology) for 3 h at 4°C with 60 l of protein G-agarose (50%), and the immunocomplexes were separated by SDS-PAGE and subjected to autoradiography.
Mesangial cells were serum-starved for 48 h in a 6-cm Petri dish, stimulated with 100 nM ET-1, and then labeled for 4 h with methioninefree Dulbecco's modified Eagle's medium supplemented with [ 35 S]methionine (100 Ci/ml) and 0.5% FBS. Cells were lysed in 800 l of ice-cold radioimmune precipitation assay buffer and immunoprecipitated with 10 l of either preimmune serum or anti-p8 antiserum as described above.
Northern Blotting-Northern blotting was performed as described (21) .
Small Interfering RNA (siRNA)-mediated Mammalian Cell RNAiComplementary RNA oligonucleotides derived from the rat nfat4 target sequence (AAGGGAATATTTGGAAAGGCCTT) were from Dharmacon. The method for rat p8 RNAi has been reported previously (9) . Deprotection and annealing of the oligonucleotides were performed according to the manufacturer's instructions. Procedures for RNAi were essentially as described by Elbashir et al. (22) . Double-stranded RNAs were introduced into mesangial cells at concentrations of 1, 5, and 10 g of oligonucleotide/6-cm dish. After an overnight incubation with the siRNA, mesangial cells were serum-starved for 48 h in RPMI 1640 medium and 0.5% FBS before proceeding. Analysis of ET-1-induced mesangial cell hypertrophy has been described previously (9) .
RESULTS

Regulation of p8 Protein Levels by the Ub/Proteasome
System-We have recently shown that p8 mRNA expression is rapidly induced by ET-1 during the onset of mesangial cell hypertrophy (9) . Little is known, however, about how this induction is reflected in changes, if any, in the in vivo levels of p8 protein. To our surprise, we were unable to detect p8 protein in lysates of mesangial cells by immunoblotting, even after treatment with ET-1 (Fig. 1B, left two lanes) . We were able to detect mesangial cell p8 only after immunoprecipitation from extracts of cells that had been metabolically labeled with [ 35 S]methionine (Fig. 1C) . In this instance, 35 S-labeled p8 was immunoprecipitated only with anti-p8 antiserum, and not with preimmune serum. Of note, ET-1 treatment for 24 h, which is sufficient to induce maximally p8 mRNA (see Fig. 4C ) (9), did not trigger increases in the p8 polypeptide (Fig. 1C) . Thus, ET-1 stimulated a very large increase in p8 mRNA expression, but failed to trigger a concomitant increase in the p8 protein (compare Figs. 1C and 4C ). Given this observation and the difficulty in detecting the endogenous p8 protein, we wondered whether p8 might be constitutively degraded. Examination of the primary sequence of p8 indicated the presence of a PEST sequence (Fig. 1A) . PEST sequences are present in many polypeptides that are subject to rapid degradation by the Ub/ proteasome system (18) . Thus, we examined the effects on p8 protein levels of the specific proteasome inhibitor lactacystin (23) . Preincubation of mesangial cells with lactacystin enables detection of endogenous p8 by immunoblotting. Under these circumstances, we observed a modest increase in the p8 protein upon subsequent treatment with ET-1 (Fig. 1B, right two  lanes) ; however, given that this increase was apparent only upon examination of lactacystin-treated cells (Fig. 1, . B, endogenous p8 is stabilized by inhibitors of the proteasome. Renal mesangial cells were pretreated for 1 h with lactacystin (Lac.) and then treated for 24 h with ET-1 as indicated. Cell extracts were prepared, subjected to SDS-PAGE, and immunoblotted with anti-p8 antibody. As a positive control, an extract from lactacystin-treated 293 cells transfected with pcDNA-p8 was run in parallel. C, mesangial cell p8 levels do not change with prolonged ET-1 stimulation. Renal mesangial cells were treated with vehicle or ET-1 for 24 h as described under "Experimental Procedures." Cells were labeled with [
35 S]methionine, and p8 was immunoprecipitated using either preimmune serum (P.I.) or anti-p8 antiserum (I). Samples were subjected to SDS-PAGE and autoradiography. D, overexpressed recombinant p8 is also stabilized by inhibition of the proteasome. 293 cells were transfected with pcDNA-p8 as indicated. Cells were treated as described for B with lactacystin as indicated. Extracts were subjected to SDS-PAGE and immunoblotted with anti-p8 antibody. E, overexpressed recombinant p8 is ubiquitinated. 293 cells were transfected with pcDNA-p8 alone or together with pCMV5-Myc-tagged Ub. Cells were treated with lactacystin as indicated, and p8-His 5 was purified from the cellular lysates with nitrilotriacetic acid-agarose. Western blotting was carried out using anti-Ub antibody (left panel) or anti-Myc antibody 9E10 (right panel).
even after ectopic overexpression, p8 protein levels remained extremely low. The addition of 10 M lactacystin to the culture medium stimulated a significant accumulation of the p8 polypeptide (Fig. 1D) , indicating regulation of p8 levels by the Ub/proteasome system. Ub is attached to target proteins via a covalent bond between a specific Lys residue in the Ub polypeptide (typically Lys 48 for proteins destined for proteasomal degradation) and a Lys residue in the target protein. We found that p8 was ubiquitinated in vivo either in cells expressing p8 alone or in cells expressing p8 and Myc-tagged recombinant Ub (Fig. 1E) . Of note, Fig. 1 (B-D) , which examines total p8 protein levels, indicates that p8 migrated at ϳ18 kDa. By contrast, Ub-p8 (Fig. 1E ) migrated at ϳ25 kDa, indicating an increase in size of ϳ7 kDa, the predicted size of the Ub polypeptide. Thus, detectable Ub-p8 appears to be monoubiquitinated. We could not detect poly-Ub-p8; whether this is due to the overall extremely poor expression of endogenous or ectopically expressed p8 or to the fact that p8 is indeed monoubiquitinated remains to be determined. Nevertheless, taken together, these results strongly indicate that p8 stability is regulated by the Ub/ proteasome system.
p8 Is a Nuclear Protein-Analysis of the primary structure of p8 revealed a canonical bipartite nuclear localization signal and a potential DNA interaction motif (Fig. 1A) (13) . We thus investigated the protein localization by overexpressing pEGFP-p8 in different cell lines. (The N-terminal EGFP tag stabilized the recombinant p8 protein, rendering it resistant to degradation.
2 ) When overexpressed as a fusion with GFP, p8 was localized in the nuclear compartment of both HeLa and NIH3T3 cells (Fig. 2A, left panels) , even in absence of external stimuli. The control EGFP protein was localized throughout the cell (Fig. 2A, right panels) . This cellular localization was not significantly modified by stimulation of the cells with epidermal growth factor or after osmotic stress with sorbitol (data not shown). Taken together, these results thus strongly suggest that p8 functions in the nuclear compartment.
p8 Is a Phosphoprotein: Regulation of Proteasomal Degradation by Protein Kinase Signaling Pathways-p8 is a highly charged protein with a large percentage of residues that are potential targets for protein kinases (Fig. 1A) . Consistent with this, p8 has been reported to be an in vitro substrate for protein kinase A and casein kinase-2 (17). We thus asked if p8 is phosphorylated in vivo. Given the low abundance of endogenous p8, we decided to examine recombinant p8 expressed in 293 cells. Cells were separately transfected with empty vector, 2 S. Goruppi, unpublished data.
FIG. 2. p8 is a nuclear protein. A,
HeLa and NIH3T3 cells were transfected with pEGFP-p8 (left panels) or pEGFP (right panels). After 24 h, cells were fixed with 3% paraformaldehyde and observed under a microscope for the fluorescent localization of the protein. B, in parallel experiments, HeLa cells were transfected, and the level of EGFP and EGFP-p8 protein expression was assessed by Western blotting using anti-GFP antibody.
pcDNA-p8-His 5 , or pEGFP-p8 and then metabolically labeled with 32 PO 4 . p8 was immunoprecipitated with either anti-GFP or anti-His antibody. Both the His 5 -and EGFP-tagged p8 proteins were heavily phosphorylated (Fig. 3A) . Both p8-His 5 and endogenous p8 migrated on SDS-polyacrylamide gels at an apparent molecular mass of 18-kDa, more than two times larger than the expected molecular mass based on amino acid composition. To determine whether this discrepancy was due to FIG. 3 . p8 is a phosphoprotein and is destabilized by phosphatase inhibition. A, in vivo p8 phosphorylation. 293 cells were transfected with the indicated plasmids and labeled metabolically with [ 32 P]orthophosphate. p8-His 5 was purified on Ni 2ϩ -nitrilotriacetic acid beads, and GFP-p8 was purified by anti-GFP immunoprecipitation. Samples were subjected to SDS-PAGE and autoradiography. B, p8 phosphatase treatment. p8-His 5 was purified from transfected 293 cells and treated with -phosphatase (PTPase) either in the presence or absence (as indicated) of the activator MnCl 2 . Phosphatase reactions were stopped with NaF as indicated. Reaction products were separated by SDS-PAGE and subjected to immunoblotting with anti-His antibody. C, phosphatase inhibition destabilizes p8 in a proteasome-dependent manner. 293 cells were transfected with vector (mock) or p8-His 5 and treated with calyculin A (calyc.) and/or lactacystin (lact.) as indicated. Extracts were prepared, subjected to SDS-PAGE, and immunoblotted with anti-His antibody. untr., untreated.
phosphorylation of the protein, we incubated the recombinant protein in vitro with -protein phosphatase. p8-His 5 was purified from transfected 293 cells and either left untreated or incubated with -phosphatase in the presence or absence of MnCl 2 , a necessary cofactor for -phosphatase activity (24) . After the treatment, the reactions were stopped with NaF, and the samples were analyzed by anti-His immunoblotting. In the presence of MnCl 2 , phosphatase selectively enhanced the mobility of p8 on SDS gels. It should be noted, however, that the dephosphorylated p8 polypeptide still migrated on SDS gels more slowly than expected, indicating that the observed migration of p8 upon SDS-PAGE cannot be attributed solely to phosphorylation.
Endogenous p8 is present at extremely low levels in vivo; and even after ectopic expression, it is difficult to detect the Cterminally tagged recombinant p8 protein in the absence of proteasome inhibitors. Many targets of the Ub/proteasome system are degraded in a manner stimulated by extracellular signaling pathways (25) . Accordingly, we wished to determine whether the signaling pathways known to regulate p8 mRNA levels might also regulate the stability of the p8 protein in vivo. Thus, 293 cells were transfected with pcDNA-p8-His 5 and treated for various times with calyculin A, a specific inhibitor of protein phosphatase-1 and -2A (26) . Calyculin A rapidly destabilized p8 to a point at which the overexpressed protein was nearly undetectable (Fig. 3C ). This destabilization was reversed with lactacystin, indicating that inhibition of a calyculin-sensitive phosphatase triggers the proteasome-dependent degradation of p8.
Bacterially expressed p8 has been reported to be a target in vitro for protein kinase A and casein kinase-2, but its regulation in vivo is still poorly understood (15) (16) (17) . Four residues on p8 (Ser 23 , Ser 27 , Ser 31 , and Thr 54 ) are potential sites for GSK3-catalyzed phosphorylation (Fig. 1A) . We therefore investigated the effects of LiCl, a GSK3 inhibitor (27) , on p8 polypeptide levels. 293 cells were transfected with the pcDNA-p8-His 5 expression vector; and after 24 h, various concentrations of LiCl were added to the medium. Fig. 4A shows that LiCl completely destabilized p8. This destabilization was specific and was not due to osmotic stress inasmuch as treatment with 20 mM NaCl had no effect on p8 stability (Fig. 4B) . Lactacystin was able to significantly prevent LiCl-stimulated p8 degradation (Fig. 4A) . These results suggest that GSK3 might prevent the proteasomal degradation of p8. GSK3 is active in resting cells (28) . Engagement of the PI3K/Akt pathway inhibits GSK3 via direct Akt-catalyzed phosphorylation of GSK3 (29 -31) . To determine whether Akt could trigger p8 destabilization, we analyzed the effect of coexpression of p8 with either kinase-dead, dominant inhibitory Akt or a membrane-targeted (myristoylated), constitutively active form of Akt. Fig. 4C shows that kinase-inactive Akt significantly increased the levels of coexpressed p8; conversely, constitutively active Akt substantially reduced the levels of coexpressed p8. These results are consistent with the idea that Akt signals to destabilize p8 in vivo. Akt is an effector for PI3K (30) . Accordingly, we wished to determine whether PI3K itself could mediate p8 destabilization. To test this, we used the specific PI3K inhibitor LY294002 (32) . Thus, 293 cells were transfected with pcDNA-p8-His 5 and treated with vehicle or LY294002. Parallel cell cultures were treated with SB203580 (32), an inhibitor of an unrelated signaling pathway (p38 MAPK). Equal amounts of total cell extracts were analyzed by Western blotting using anti-His antibody. Consistent with the idea that recruitment of PI3K destabilizes p8, blocking PI3K-dependent signaling with LY294002 significantly stabilized p8. We therefore asked whether p8 might be a direct GSK3 substrate. Fig. 4E shows that wild-type GSK3␤ (but not kinase-dead GSK3␤) was able to phosphorylate the bacterially expressed recombinant p8 protein. Taken together, our results strongly suggest that recruitment of PI3K via Akt-mediated inhibition of GSK3 leads to destabilization of the p8 protein.
ET-1 Induction of p8 and Renal Mesangial Cell Hypertrophy Require NFAT4 -ET-1 induces cardiomyocyte hypertrophy through a PI3K/Akt/GSK3-and NFAT4-dependent mechanism (7, 33, 34) . It is believed that ET-1 recruitment of PI3K and Akt triggers GSK3 inhibition (28, 35) . This prevents GSK3-catalyzed inhibitory phosphorylation of NFAT4 (36, 37) . ET-1 also stimulates Ca 2ϩ uptake, which, in turn, activates the calciumdependent protein phosphatase-2B. Protein phosphatase-2B then dephosphorylates NFAT4, thereby enabling the translocation of NFAT4 to the nucleus, where it transactivates genes necessary for propagating hypertrophy (28, 33, 37, 38) . We have previously shown that FK506, a protein phosphatase-2B inhibitor, is able to block ET-1-induced mesangial cell hypertrophy as well as induction of the p8 gene (9) . We have also shown that p8 gene induction is required for mesangial cell hypertrophy (9) . These findings compelled us to ask whether NFAT4 is required for mesangial cell hypertrophy. We employed mammalian cell RNAi mediated by siRNAs. Doublestranded oligonucleotides corresponding to sequences from rat NFAT4 or p8 were introduced into mesangial cells. NFAT4 expression was analyzed by Western blotting. Introduction of NFAT4 oligonucleotides into mesangial cells substantially reduced endogenous NFAT4 protein levels without affecting NFAT1 levels. A double-stranded RNA corresponding to a sequence from rat Ha-Ras used as a negative control was without effect on NFAT4 levels (Fig. 5A ). Fig. 4B shows that introduction of NFAT4 siRNA oligonucleotides completely prevented ET-1-induced renal mesangial hypertrophy. An siRNA construct corresponding to the human p8 gene, which had no effect on rat renal mesangial cell p8 mRNA (data not shown), failed to blunt ET-1-stimulated rat renal mesangial cell hypertrophy (Fig. 5B) . Having previously defined p8 as a gene induced in rat mesangial cells by ET-1 and required for ET-1-stimulated hypertrophy (9), we sought to determine whether p8 gene induction requires NFAT4. As expected, treatment of rat renal mesangial cells with siRNA specific for the rat p8 gene significantly reduced both basal and ET-1-induced p8 gene expression (Fig. 5C ). Of note, introduction of rat NFAT4 siRNA also significantly reduced ET-1 induction of the p8 gene (Fig.  5C ). The results in Fig. 5 (B and C) strongly indicate that NFAT4 is required for both ET-1-induced mesangial cell hypertrophy and p8 gene induction. Coupled with our previous observation that the p8 gene is required for ET-1-stimulated mesangial cell hypertrophy (9), these findings are consistent with the idea that mesangial cell hypertrophy requires in part PI3K/NFAT4-dependent induction of p8 mRNA.
DISCUSSION
Our results present an interesting paradox. We found that p8 mRNA is rapidly and stably induced by ET-1 and that p8 is required for ET-1-stimulated renal mesangial cell hypertrophy (9) . Our findings presented herein and elsewhere indicate that induction of p8 mRNA and mesangial cell hypertrophy require recruitment of the PI3K pathway and its effector NFAT4. On the other hand, our studies of the p8 protein indicate that it is extremely unstable in vivo, subject to swift degradation by the Ub/proteasome pathway. Of note, we found that what little detectable p8 protein is present in mesangial cells is not increased upon stimulation of the cells with ET-1. Surprisingly, we also observed that the PI3K pathway, probably through Akt-mediated inhibition of GSK3, actually promotes the proteasomal degradation of p8. Thus, we found that calyculin A triggers the destabilization of the p8 protein, likely due to inhibition of phosphatases that inactivate Akt. The resulting increased Akt-mediated phosphorylation and inhibition of GSK3 in turn lead to p8 destabilization (Fig. 6) . Thus, although p8 is required for ET-1-stimulated hypertrophy, the common signaling pathways regulating p8 gene transcription and p8 protein stability evidently function at cross-purposes, with ET-1 triggering both a PI3K-dependent increase in p8 mRNA and a PI3K-and proteasome-dependent degradation of the p8 protein (Fig. 6) . The apparent consequence of this is that p8 protein levels remain constant during prolonged ET-1 stimulation (Fig. 1B) . Based on these findings, it is plausible to speculate that this constant level of p8 protein forms part of the mechanism by which ET-1 promotes mesangial cell hypertrophy (Fig. 6) .
Why does ET-1 trigger both degradation of renal mesangial cell p8 protein and production of p8 mRNA? It is possible that p8 degradation is part of a general stress response mechanism. Indeed, the proteasome is often recruited to its targets in response to stressful or pro-inflammatory stimuli, and the p8 protein is degraded "nonspecifically" consequent to inhibition of GSK3. The induction of p8 mRNA could be compensatory, serving to protect p8 protein levels during stress. Alternatively, the degradation of p8 and its subsequent induction could be kinetically separated. Induction of mesangial cell p8 mRNA is first detected within 1 h of ET-1 stimulation. By contrast, FIG. 4 . PI3K/GSK3-dependent destabilization of p8. A, inhibition of GSK3 destabilizes p8 in a proteasome-dependent manner. 293 cells were transfected with vector (mock) or p8-His 5 and treated with LiCl and/or lactacystin (lac) as indicated. Extracts were prepared, subjected to SDS-PAGE, and immunoblotted with anti-p8 antibody. Recombinant (rec) p8 produced in bacteria served as a marker for p8 migration on the gel. untr., untreated. B, specificity of the LiCl effect. Cells were transfected with p8-His 5 treated with LiCl or NaCl as described for A. Extracts were prepared, subjected to SDS-PAGE, and immunoblotted with anti-p8 antibody. C, activated Akt destabilizes p8, whereas dominant inhibitory Akt stabilizes p8. Cells were transfected with p8-His 5 and either Myc-tagged myristoylated active Akt (myr Akt) or kinase-inactive Akt (KM Akt) as indicated. Extracts were prepared, subjected to SDS-PAGE, and immunoblotted with anti-p8 or anti-Myc antibody as indicated. WB, Western blot. D, inhibition of PI3K stabilizes p8. Cells were transfected with vector or p8-His 5 and treated with vehicle, SB203580, or LY294002. Extracts were prepared, subjected to SDS-PAGE, and immunoblotted with anti-p8 antibody. E, p8 is an in vitro substrate for GSK3. 293 cells were transfected with either wild-type (wt) or kinase-dead (kϪ) GSK3␤ (Myc-tagged). The overexpressed kinase was isolated by immunoprecipitation and incubated with bacterially expressed recombinant p8 in the presence of [ 32 P]ATP (upper panel). Separate Western blots of total cellular lysates were developed using antibody 9E10 (lower panel).
activation of protein kinase B/Akt and inhibition of GSK3 (and presumably inhibition of GSK3-catalyzed p8 phosphorylation) is much more rapid (9) . Destruction of the p8 protein could be required for the more acute effects of ET-1, whereas subsequent restoration of p8, consequent to ET-1-stimulated induction of p8 mRNA, could function in the more long-term effects of ET-1 such as hypertrophy. Inasmuch as ET-1 activation of NFAT4 (through PI3K) appears to be required for p8 mRNA induction (Fig. 5) , we do not believe that p8 polypeptide degradation serves as a trigger for induction of p8 mRNA. Instead, it is likely that these pathways bifurcate downstream of PI3K itself. As for the binding of NFAT4 to the p8 promoter, both the mouse and human p8 promoters contain a consensus NFAT cis-element; however, pending completion of the rat genome sequencing effort, we do not know whether a similar NFAT cis-element is conserved in rat. Thus, although NFAT4 is necessary for ET-1-stimulated mesangial cell hypertrophy, it is still unclear whether NFAT4 acts directly on the rat p8 promoter or mediates p8 mRNA induction indirectly.
p8 is a putative basic helix-loop-helix protein, the function of which remains nebulous. p8 mRNA is potently induced during acute pancreatitis (10) and is constitutively elevated in some tumor lines (14) . These findings have suggested a role for p8 in stress responses and proliferative control. Consistent with a function in proliferation, disruption of the murine p8 gene suppresses the tumorigenesis (measured as soft agar colony formation and establishment of xenograft tumors) of knockout fibroblasts ectopically expressing transforming ras and adenoviral E1A (15) . By contrast, however, p8 Ϫ/Ϫ fibroblasts proliferate more quickly in culture than do p8 ϩ/ϩ cells (15, 16) . It is therefore possible that p8 is necessary for anchorage-independent proliferation.
p8 is a nuclear protein, and there is some evidence that p8 functions in transcriptional regulation. Thus, yeast two-hybrid screening indicates that p8 can bind to PTIP (Pax2 transactivation domain-interacting protein), a polypeptide that, in turn, binds and inhibits the paired box transcription factor Pax2 (39) . Transfection and reporter gene experiments suggest that p8 reverses PTIP repression of Pax2. Pax2 is required during embryonic development for proper establishment of the renal epithelium. A hallmark feature of hypertrophy is the reactivation of embryonic genes (33, 34, 40 ). It will be important to determine whether p8 might potentiate Pax2 function in mesangial cell hypertrophy. Rat renal mesangial cells were subjected to NFAT4 RNAi or to a control RNAi using a nonspecific RNAi oligonucleotide corresponding to human p8 (hp8). Cells were then treated with vehicle (untreated (unt)) or ET-1 as indicated and assayed for hypertrophy. C, ET-1 induction of p8 mRNA requires NFAT4. Rat renal mesangial cells were subjected to rat-specific NFAT4 or p8 RNAi as indicated or were treated with oligofection vehicle alone. Cells were then treated with ET-1 for 24 h. p8 and glyceraldehyde-3-phosphate dehydrogenase (gapdh) mRNA levels were measured by Northern blotting; NFAT4 levels were determined by immunoblotting. end and End., endogenous p8.
FIG. 6.
Model for the signal-dependent stabilization of renal mesangial cell p8 protein and induction of p8 mRNA. The combined effects of these two pathways maintain a constant level of p8 protein during prolonged ET-1 stimulation. See "Discussion" for details. PDK1, 3-phosphoinositide-dependent kinase-1; PP2B, protein phosphatase-2B; PPase, phosphatase.
